Mutation Characteristics of Primary Hyperoxaluria in the Chinese Population and Current International Diagnosis and Treatment Status.
中國人群原發性高草酸尿症的突變特徵及目前國際診斷與治療現狀。
Kidney Dis (Basel) 2024-08-12
Is withdrawal of nocturnal hyperhydration possible in children with primary hyperoxaluria treated with RNAi?
原發性高草酸血症患兒接受RNAi治療後,是否可以停止夜間過度水化療法?
J Nephrol 2023-07-18
Diagnostic policies on nephrolithiasis/nephrocalcinosis of possible genetic origin by Italian nephrologists: a survey by the Italian Society of Nephrology with an emphasis on primary hyperoxaluria.
義大利腎臟科醫師對可能具有遺傳起源之腎結石/腎鈣化的診斷政策:以義大利腎臟學會進行的調查,重點放在原發性高草酸尿症。
J Nephrol 2023-08-04
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium.
原發性高草酸血症1型腎衰竭的決定因素:歐洲高草酸血症聯盟的研究發現。
Kidney Int Rep 2023-11-29
Clinical characteristics, genetic profile and short-term outcomes of children with primary hyperoxaluria type 2: a nationwide experience.
原發性草酸尿症2型兒童的臨床特徵、基因檔案及短期結果:全國性經驗。
Pediatr Nephrol 2024-02-28
Primary hyperoxaluria in adults and children: a nationwide cohort highlights a persistent diagnostic delay.
成人和兒童的原發性高草酸血症:全國性群體突顯持續的診斷延遲。
Clin Kidney J 2024-05-13
Lumasiran treatment in pediatric patients with PH1: real-world data within a compassionate use program in Italy.
羥丙酮酸尿症小兒患者的 Lumasiran 治療:意大利一項富同情心使用計劃中的實際數據。
Clin Kidney J 2024-05-14